Literature DB >> 33648431

Construction and cryopreservation of an artificial ovary in cancer patients as an element of cancer therapy and a promising approach to fertility restoration.

Jing Chen1, Plamen Todorov2, Evgenia Isachenko1, Gohar Rahimi1, Peter Mallmann1, Vladimir Isachenko1.   

Abstract

The proportion of cancer patients that survive is increasing because of improvements in cancer therapy. However, some cancer treatments, such as chemo- and radio-therapies, can cause considerable damage to reproductive function. The issue of fertility is paramount for women of childbearing age once they are cured from cancer. For those patients with prepubertal or haematogenous cancer, the possibilities of conventional fertility treatments, such as oocyte or embryo cryopreservation and transplantation, are limited. Moreover, ovarian tissue cryopreservation as an alternative to fertility preservation has limitations, with a risk of re-implanting malignant cells in patients who have recovered from potentially fatal malignant disease. One possible way to restore fertility in these patients is to mimic artificially the function of the natural organ, the ovary, by grafting isolated follicles embedded in a biological scaffold to their native environment. Construction and cryopreservation of an artificial ovary might offer a safer alternative option to restore fertility for those who cannot benefit from traditional fertility preservation techniques. This review considers the protocols for constructing an artificial ovary, summarises advances in the field with potential clinical application, and discusses future trends for cryopreservation of these artificial constructions.

Entities:  

Keywords:  Cancer; artificial ovary; cryopreservation; fertility preservation; scaffold; tissue engineering

Year:  2021        PMID: 33648431     DOI: 10.1080/14647273.2021.1885756

Source DB:  PubMed          Journal:  Hum Fertil (Camb)        ISSN: 1464-7273            Impact factor:   2.767


  4 in total

Review 1.  Artificial Ovary for Young Female Breast Cancer Patients.

Authors:  Jing Chen; Luz Angela Torres-de la Roche; Ulf D Kahlert; Vladimir Isachenko; Hui Huang; Jörg Hennefründ; Xiaohong Yan; Qionghua Chen; Wenjie Shi; Youzhu Li
Journal:  Front Med (Lausanne)       Date:  2022-03-17

Review 2.  Ovarian tissue bank for fertility preservation and anti-menopause hormone replacement.

Authors:  Jing Chen; Yan Han; Wenjie Shi; Xiaohong Yan; Yingying Shi; Ye Yang; Hong Gao; Youzhu Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-09       Impact factor: 6.055

Review 3.  A Warning Call for Fertility Preservation Methods for Women Undergoing Gonadotoxic Cancer Treatment.

Authors:  Claudia Mehedintu; Francesca Frincu; Andreea Carp-Veliscu; Ramona Barac; Dumitru-Cristinel Badiu; Anca Zgura; Monica Cirstoiu; Elvira Bratila; Mihaela Plotogea
Journal:  Medicina (Kaunas)       Date:  2021-12-08       Impact factor: 2.430

4.  The challenge of ovarian tissue culture: 2D versus 3D culture.

Authors:  Ana Sofia Pais; Sandra Reis; Mafalda Laranjo; Francisco Caramelo; Fátima Silva; Maria Filomena Botelho; Teresa Almeida-Santos
Journal:  J Ovarian Res       Date:  2021-11-01       Impact factor: 4.234

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.